1. A safety evaluation of sucroferric oxyhydroxide for the treatment of hyperphosphatemia. Issue 12 (2nd December 2021) Authors: Sprague, Stuart M.; Ketteler, Markus Journal: Expert opinion on drug safety Issue: Volume 20:Issue 12(2021) Page Start: 1463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An expert update on novel therapeutic targets for hyperphosphatemia in chronic kidney disease: preclinical and clinical innovations. (3rd May 2020) Authors: Cozzolino, Mario; Ketteler, Markus; Wagner, Carsten Alexander Journal: Expert opinion on therapeutic targets Issue: Volume 24:Number 5(2020:May) Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Issue 1 (29th January 2016) Authors: Brandenburg, Vincent M.; Kramann, Rafael; Rothe, Hansjörg; Kaesler, Nadine; Korbiel, Joanna; Specht, Paula; Schmitz, Sophia; Krüger, Thilo; Floege, Jürgen; Ketteler, Markus Journal: Nephrology dialysis transplantation Issue: Volume 32:Issue 1(2017) Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials. Issue 7 (27th February 2019) Authors: Zoccali, Carmine; Blankestijn, Peter J; Bruchfeld, Annette; Capasso, Giovambattista; Fliser, Danilo; Fouque, Denis; Goumenos, Dimitrios; Ketteler, Markus; Massy, Ziad; Rychlık, Ivan; Jose Soler, Maria; Stevens, Kate; Spasovski, Goce; Wanner, Christoph Journal: Nephrology dialysis transplantation Issue: Volume 34:Issue 7(2019) Page Start: 1112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials. Issue 8 (12th April 2019) Authors: Zoccali, Carmine; Blankestijn, Peter J; Bruchfeld, Annette; Capasso, Giovambattista; Fliser, Danilo; Fouque, Denis; Goumenos, Dimitrios; Ketteler, Markus; Massy, Ziad; Rychlık, Ivan; Soler, Maria Jose; Stevens, Kate; Spasovski, Goce; Wanner, Christoph Journal: Nephrology dialysis transplantation Issue: Volume 35:Issue 8(2020) Page Start: 1453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patients. (23rd July 2013) Authors: Sharma, Amit; Ketteler, Markus; Marshall, Thomas S.; Khan, Samina S.; Schumock, Glen T. Journal: Journal of medical economics Issue: Volume 16:Number 9(2013) Page Start: 1129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patients. (23rd July 2013) Authors: Sharma, Amit; Ketteler, Markus; Marshall, Thomas S.; Khan, Samina S.; Schumock, Glen T. Journal: Journal of medical economics Issue: Volume 16:Number 9(2013) Page Start: 1129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Detecting high-risk chronic kidney disease–mineral bone disorder phenotypes among patients on dialysis: a historical cohort study. Issue 4 (27th August 2018) Authors: Neri, Luca; Kreuzberg, Ursula; Bellocchio, Francesco; Brancaccio, Diego; Barbieri, Carlo; Canaud, Bernard; Stuard, Stefano; Ketteler, Markus Journal: Nephrology dialysis transplantation Issue: Volume 34:Issue 4(2019) Page Start: 682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study. Issue 5 (8th May 2021) Authors: Bushinsky, David A.; Raggi, Paolo; Bover, Jordi; Ketteler, Markus; Bellasi, Antonio; Rodriguez, Mariano; Sinha, Smeeta; Garg, Rekha; Perelló, Joan; Gold, Alex; Chertow, Glenn M. Other Names: author non-byline.; Nash Kevin W. author non-byline.; Kaskas Marwan O. author non-byline.; Martin Edouard Rene author non-byline.; Bernardo Marializa Victorino author non-byline.; Mehta Bhasker author non-byline.; Hon George author non-byline.; Meyer Jill Marie author non-byline.; Steer Dylan Li... Journal: Clinical journal of the American Society of Nephrology Issue: Volume 16:Issue 5(2021) Page Start: 736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. ERA-EDTA invests in transformation to greener health care. Issue 6 (25th May 2018) Authors: Blankestijn, Peter J; Arici, Mustafa; Bruchfeld, Annette; Capasso, Giovambattista; Fliser, Danilo; Fouque, Denis; Goumenos, Dimitrios; Ketteler, Markus; Malyszko, Jolanta; Massy, Ziad; Rychlík, Ivan; Spasovski, Goce; Zoccali, Carmine Journal: Nephrology dialysis transplantation Issue: Volume 33:Issue 6(2018) Page Start: 901 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗